GB0116619D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB0116619D0
GB0116619D0 GBGB0116619.8A GB0116619A GB0116619D0 GB 0116619 D0 GB0116619 D0 GB 0116619D0 GB 0116619 A GB0116619 A GB 0116619A GB 0116619 D0 GB0116619 D0 GB 0116619D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0116619.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0116619.8A priority Critical patent/GB0116619D0/en
Publication of GB0116619D0 publication Critical patent/GB0116619D0/en
Priority to PL02367624A priority patent/PL367624A1/en
Priority to IL15957602A priority patent/IL159576A0/en
Priority to CNA028171888A priority patent/CN1553815A/en
Priority to CA002453111A priority patent/CA2453111A1/en
Priority to KR10-2004-7000153A priority patent/KR20040010841A/en
Priority to JP2003511869A priority patent/JP2004534093A/en
Priority to RU2004102393/15A priority patent/RU2004102393A/en
Priority to PCT/GB2002/003092 priority patent/WO2003006064A1/en
Priority to BR0210898-4A priority patent/BR0210898A/en
Priority to EP02740940A priority patent/EP1406662A1/en
Priority to HU0400115A priority patent/HUP0400115A3/en
Priority to ARP020102523A priority patent/AR037138A1/en
Priority to IS7097A priority patent/IS7097A/en
Priority to ZA200400079A priority patent/ZA200400079B/en
Priority to NO20040047A priority patent/NO20040047L/en
Priority to CO04000761A priority patent/CO5560585A2/en
Priority to MXPA04000028A priority patent/MXPA04000028A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
GBGB0116619.8A 2001-07-07 2001-07-07 Formulation Ceased GB0116619D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB0116619.8A GB0116619D0 (en) 2001-07-07 2001-07-07 Formulation
HU0400115A HUP0400115A3 (en) 2001-07-07 2002-07-03 Pharmaceutical composition for the intramuscular administration of fulvestrant
PCT/GB2002/003092 WO2003006064A1 (en) 2001-07-07 2002-07-03 Pharmaceutical formulation for the intramuscular administration of fulvestrant
EP02740940A EP1406662A1 (en) 2001-07-07 2002-07-03 Pharmaceutical formulation for the intramuscular administration of fulvestrant
CNA028171888A CN1553815A (en) 2001-07-07 2002-07-03 Pharmaceutical formulation for the intramuscular administration of fulvestrant
CA002453111A CA2453111A1 (en) 2001-07-07 2002-07-03 Pharmaceutical formulation for the intramuscular administration of fulvestrant
KR10-2004-7000153A KR20040010841A (en) 2001-07-07 2002-07-03 Pharmaceutical formulation for the intramuscular administration of fulvestrant
JP2003511869A JP2004534093A (en) 2001-07-07 2002-07-03 Pharmaceutical formulation for intramuscular administration of fulvestrant
RU2004102393/15A RU2004102393A (en) 2001-07-07 2002-07-03 PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INTRODUCTION OF A FULVESTRANT
PL02367624A PL367624A1 (en) 2001-07-07 2002-07-03 Pharmaceutical formulation for the intramuscular administration of fulvestrant
BR0210898-4A BR0210898A (en) 2001-07-07 2002-07-03 Pharmaceutical formulation, unit dose thereof, use of powder in the preparation of a pharmaceutical formulation, and sterile syringe or vial
IL15957602A IL159576A0 (en) 2001-07-07 2002-07-03 Pharmaceutical formulation for the intramuscular administration of fulvestrant
ARP020102523A AR037138A1 (en) 2001-07-07 2002-07-05 PHARMACEUTICAL FORMULATION, USE OF FULVESTRANT IN THE PREPARATION OF THE SAME AND STERILE SYRINGE OR ROAD THAT INCLUDE SUCH FORMULATION
IS7097A IS7097A (en) 2001-07-07 2004-01-05 Medicinal product for the administration of intramuscular filvestrant
ZA200400079A ZA200400079B (en) 2001-07-07 2004-01-06 Pharmaceutical formulation for the intramuscular administration of fulvestrant.
NO20040047A NO20040047L (en) 2001-07-07 2004-01-06 Pharmaceutical formulation for intramuscular administration of fulvestrant
CO04000761A CO5560585A2 (en) 2001-07-07 2004-01-07 PHARMACEUTICAL FORMULATION FOR INTRAMUSCULAR ADMINISTRATION OF FULVESTRANT
MXPA04000028A MXPA04000028A (en) 2001-07-07 2004-01-07 Pharmaceutical formulation for the intramuscular administration of fulvestrant.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0116619.8A GB0116619D0 (en) 2001-07-07 2001-07-07 Formulation

Publications (1)

Publication Number Publication Date
GB0116619D0 true GB0116619D0 (en) 2001-08-29

Family

ID=9918095

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0116619.8A Ceased GB0116619D0 (en) 2001-07-07 2001-07-07 Formulation

Country Status (3)

Country Link
KR (1) KR20040010841A (en)
GB (1) GB0116619D0 (en)
ZA (1) ZA200400079B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100966597B1 (en) * 2008-07-03 2010-06-29 김진수 Damper apparatus for overpressure exhaust
MX2018013414A (en) * 2016-05-06 2019-06-06 Eagle Pharmaceuticals Inc Fulvestrant formulations and methods of their use.

Also Published As

Publication number Publication date
ZA200400079B (en) 2005-04-06
KR20040010841A (en) 2004-01-31

Similar Documents

Publication Publication Date Title
EG24074A (en) Formulation
DE60231477D1 (en) Imidazolderivate
GB2381204B (en) Putter-heads
GB0000891D0 (en) Formulation
EP1353546A4 (en) Specification
GB0125492D0 (en) Formulation
GB0101992D0 (en) Pesticidal formulation
GB0114007D0 (en) Oilgonucleotides
GB2396812B (en) Formulation
GB2375048B (en) Formulation
GB0116619D0 (en) Formulation
GB0106031D0 (en) Use
IL147063A0 (en) Pesticidal formulation
GB0112497D0 (en) Formulation
GB0115893D0 (en) Formulations
GB0127489D0 (en) Autolight
GB0107226D0 (en) Formulations
CA93959S (en) Tilt-latch
GB0118830D0 (en) Disinfectant formulation
GB0121452D0 (en) Disinfectant formulation
GB0004124D0 (en) Formulation
GB0010846D0 (en) Formulation
GB0007112D0 (en) Formulation
GB0023069D0 (en) Formulation
GB0001144D0 (en) Glysophosate formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)